logo-loader
LSE:SCLP FRA:SCP

Scancell Holdings PLC

Market:
LSE
Market Cap:
£81 m
Price
12.88 GBX
Change
-2.83%
52 weeks high
18.00
52 weeks low
4.19

In brief

Scancell's primary focus is to develop innovative immunotherapies for cancer that stimulate the body’s own immune system. A key challenge in the fight against cancer is that many tumours successfully evade the body’s own natural defences. Scancell’s mission is to overcome this by developing products that stimulate the immune system to treat or prevent cancer.

Deep dive We explore the investor case for growth companies

Snapshot

Here we take a closer look at Scancell, which is at the vanguard of immuno-oncology